Childhood obesity complicating the differential diagnosis of maturity-onset diabetes of the young and type 2 diabetes

Pediatric Diabetes

Volumn 9, Issue 1, 2008, Pages 60-64

  Weintrob, Naomi ^a,b   Stern, Eti ^b   Klipper Aurbach, Yaffa ^a   Phillip, Moshe ^a,b   Gat Yablonski, Galia ^a,b  

^a SCHNEIDER CHILDREN S MEDICAL CENTER OF ISRAEL   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Childhood obesity; DGGE; HNF 1 ; MODY; TCF1

Indexed keywords

C PEPTIDE; CELL ANTIBODY; HEPATOCYTE NUCLEAR FACTOR 1ALPHA; INSULIN; METFORMIN; SULFONYLUREA;

ADOLESCENT; ARTICLE; CASE REPORT; CHILDHOOD DISEASE; DIET THERAPY; DIFFERENTIAL DIAGNOSIS; FAMILY HISTORY; GENE MUTATION; GENETIC ANALYSIS; HUMAN; HYPERGLYCEMIA; IMPAIRED GLUCOSE TOLERANCE; INSULIN RESISTANCE; ISCHEMIC HEART DISEASE; MALE; MATURITY ONSET DIABETES MELLITUS; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SYSTOLIC HYPERTENSION;

ADOLESCENT; DIABETES MELLITUS, TYPE 2; DIAGNOSIS, DIFFERENTIAL; FEMALE; HEPATOCYTE NUCLEAR FACTOR 1-ALPHA; HUMANS; HYPERGLYCEMIA; MALE; MUTATION; OBESITY;

EID: 38349115695     PISSN: 1399543X     EISSN: 13995448     Source Type: Journal    
DOI: 10.1111/j.1399-5448.2007.00259.x     Document Type: Article

References (29)

1. Strauss RS, Pollock HA. Epidemic increase in childhood overweight, 1986-1998. JAMA 2001: 286: 2845-2848.
2. Nesmith JD. Type 2 diabetes mellitus in children and adolescents. Pediatr Rev 2001: 22: 147-152.
3. Onkamo P, Vaananen S, Karvonen M, Tuomilehto J. Worldwide increase in incidence of type 1 diabetes: The analysis of the data on published incidence trends. Diabetologia 1999: 42: 1395-1403.
4. Libman IM, Pietropaolo M, Arslanian SA, Le Porte RE, Becker DJ. Changing prevalence of overweight children and adolescents at onset of insulin-treated diabetes. Diabetes Care 2003: 26: 2871-2875.
5. Velho G, Robert JJ. Maturity-onset diabetes of the young (MODY): Genetic and clinical characteristics. Horm Res 2002: 57 (Suppl. 1): 29-33.
6. Ledermann HM. Maturity-onset diabetes of the young (MODY) at least ten times more common in Europe than previously assumed. Diabetologia 1995: 38: 1482.
7. Raeder H, Johansson S, Holm PI et al. Mutations in the CEL VNTR cause a syndrome of diabetes and pancreatic exocrine dysfunction. Nat Genet 2005: 38: 54-62.
8. Winter WE. Molecular and biochemical analysis of the MODY syndromes. Pediatr Diabetes 2000: 1: 88-118.
9. Fajans SS, Bell GI, Polonsky KS. Molecular mechanism and clinical pathophysiology of maturity-onset diabetes of the young. N Engl J Med 2001: 345: 971-980.
10. Doria A, Yang Y, Malecki M et al. Phenotypic characteristics of early onset autosomal dominant type 2 diabetes unlinked to known maturity onset diabetes of the young (MODY) genes. Diabetes Care 1999: 22: 253-261.
11. Fajans SS, Bell GI. Maturity-onset diabetes of the young: A model for genetic studies of diabetes mellitus. In: LeRoith D, Taylor SI, Olefsky JM, eds. Diabetes Mellitus: A Fundamental and Clinical Text, 2nd edn. Philadelphia, PA: Lippincott Williams & Wilkins, 2000: 691-705.
12. Grubin CE, Daniels T, Toivola B et al. A novel radioligand-binding assay to determine diagnostic accuracy of isoform-specific glutamic acid decarboxylase antibodies in childhood IDDM. Diabetologia 1994: 37: 344-350.
13. Lazar L, Ofan R, Weintrob N et al. Heat shock protein peptide DiaPep277 treatment in children with newly diagnosed type 1 diabetes: A randomized double-blind phase II study. Diabetes Metab Res Rev 2007: 23: 286-291.
14. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure of extracting DNA from human nucleated cells. Nucleic Acids Res 1988: 16: 1215-1219.
15. Haskin O, Lazar L, Phillip M, Salvatori R, Alba M, Gat-Yablonski G. A novel mutation in the growth hormone releasing hormone receptor gene in Israeli Arab families. J Endocrinol Invest 2006: 29: 122-130.
16. Yamagata K, Furuta H, Oda N et al. Mutations in the hepatocyte nuclear factor-1-alpha gene in maturity-onset diabetes of the young (MODY3). Nature 1996: 384: 455-457.
17. Sellers EAC, Triggs-Raine B, Rockman-Greenberg C, Dean HJ. The prevalence of the HNF-1 G319S mutation in Canadian Aboriginal youth with type 2 diabetes. Diabetes Care 2002: 25: 2202-2206.
18. Tonnoka N, Tomura H, Takahashi Y et al. High frequency of mutations in the HNF-1a gene (TCF1) in non-obese patients with diabetes of youth in Japanese and identification of a case of digenic inheritance. Diabetologia 2002: 45: 1709-1712.
19. Wilkin TJ. The accelerator hypothesis: Weight gain as the missing link between type 1 and type 2 diabetes. Diabetologia 2001: 44: 914-922.
20. Frayling TM, Evans JC, Badman MP et al. Beta-cell genes and diabetes molecular and clinical characterization of mutations in transcription factors. Diabetes 2001: 50: S94-S100.
21. Aguilera E, Casamitjana R, Ercilla G et al. Clinical characteristics, beta-cell function, HLA class II and mutations in MODY genes in non-paediatric subjects with type 1 diabetes without pancreatic autoantibodies. Diabet Med 2004: 22: 137-143.
22. Porter JR, Barrett TG. Acquired non-type 1 diabetes in childhood: subtypes, diagnosis, and management. Arch Dis Child 2004: 89: 1138-1144.
23. Sobngwi E, Boudou P, Mauvais-Jarvis F et al. Effect of a diabetic environment in utero on predisposition to type 2 diabetes. Lancet 2003: 361: 1861-1865.
24. McLean M, Chipps D, Cheung NW. Mother to child transmission of diabetes mellitus: Does gestational diabetes program type 2 diabetes in the next generation? Diabet Med 2006: 23: 1213-1215.
25. Tronche F, Yaniv M. HNF1, a homeoprotein member of the hepatic transcription regulatory network. Bioessays 1992: 14: 579-587.
26. Wang H, Antinozzi PA, Hagenfeldt KA, Maechler P, Wollheim CB. Molecular targets of a human HNF1 alpha mutation responsible for pancreatic beta-cell dysfunction. EMBO J 2000: 19: 4257-4264.
27. Yamagata K, Yank Q, Yamamoto K et al. Mutation P291fsinsC in the transcription factor hepatocyte nuclear factor-alpha is dominant negative. Diabetes 1998: 47: 1231-1235.
28. Kaufman F. Type 2 diabetes mellitus in children and youth: A new epidemic. J Pediatr Endocrinol Metab 2002: 15 (Suppl. 2): 737-744.
29. Pearson ER, Liddell WG, Shepherd M, Corrall RJ, Hattersley AT. Sensitivity to sulphonylureas in patients with hepatocyte nuclear factor-1 alpha gene mutations: Evidence for pharmacogenetics in diabetes. Diabet Med 2000: 17: 543-545.